CARMA facility in Utah has developed a method to measure atrial fibrosis with cardiac MRI to see if it correlates with ablation success. Currently in long term, multi-facility studies. It is difficult to guesstimate why one patient has a higher level of fibrosis than another. I tested in the 3rd category with lower odds of ablation success, but couldn't tolerate drug side effects and really trusted the skill of my EP, so proceeded anyway.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.